Total Payments
$213,637
2024 Payments
$34,410
Companies
33
Transactions
395
Medicare Patients
6,989
Medicare Billing
$373,347
Payment Breakdown by Category
Other$138,812 (65.0%)
Consulting$46,303 (21.7%)
Travel$17,160 (8.0%)
Food & Beverage$11,348 (5.3%)
Education$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $138,812 | 47 | 65.0% |
| Consulting Fee | $46,303 | 14 | 21.7% |
| Travel and Lodging | $17,160 | 85 | 8.0% |
| Food and Beverage | $11,348 | 248 | 5.3% |
| Education | $13.89 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $81,538 | 78 | $0 (2023) |
| Boston Scientific Corporation | $36,861 | 66 | $0 (2024) |
| Medtronic, Inc. | $36,732 | 73 | $0 (2024) |
| AngioDynamics, Inc. | $20,357 | 7 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $16,186 | 20 | $0 (2018) |
| BioStable Science & Engineering | $9,952 | 6 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $5,097 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,598 | 43 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,082 | 8 | $0 (2019) |
| Merck Sharp & Dohme LLC | $674.32 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,410 | 76 | Medtronic, Inc. ($28,693) |
| 2023 | $10,522 | 35 | Boston Scientific Corporation ($4,929) |
| 2022 | $23,527 | 31 | AngioDynamics, Inc. ($11,773) |
| 2021 | $25,418 | 26 | BioStable Science & Engineering ($9,800) |
| 2020 | $34,595 | 52 | Amarin Pharma Inc. ($22,612) |
| 2019 | $66,651 | 95 | Amarin Pharma Inc. ($55,112) |
| 2018 | $2,475 | 36 | Otsuka America Pharmaceutical, Inc. ($810.13) |
| 2017 | $16,039 | 44 | Otsuka America Pharmaceutical, Inc. ($15,376) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $236.51 | General |
| Category: Hypertension | ||||||
| 12/23/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $32.00 | General |
| Category: Hypertension | ||||||
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/16/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,568.75 | General |
| Category: Renal Denervation System | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $99.79 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/22/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Travel and Lodging | In-kind items and services | $1,487.68 | General |
| Category: Stents | ||||||
| 10/15/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Stents | ||||||
| 10/15/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Stents | ||||||
| 10/15/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $35.12 | General |
| Category: Stents | ||||||
| 10/14/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,560.00 | General |
| Category: Hypertension | ||||||
| 10/14/2024 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,443.75 | General |
| 10/14/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Travel and Lodging | In-kind items and services | $229.00 | General |
| Category: Stents | ||||||
| 10/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $172.50 | General |
| Category: Renal Denervation System | ||||||
| 10/14/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Travel and Lodging | In-kind items and services | $40.81 | General |
| Category: Stents | ||||||
| 10/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Travel and Lodging | In-kind items and services | $23.00 | General |
| Category: Renal Denervation System | ||||||
| 10/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Renal Denervation System | ||||||
| 10/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Renal Denervation System | ||||||
| 10/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Not Applicable | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $236.51 | General |
| Category: Hypertension | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $32.00 | General |
| Category: Hypertension | ||||||
| 09/25/2024 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $109.96 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,898 | 2,169 | $246,294 | $78,740 |
| 2022 | 24 | 1,924 | 2,215 | $272,313 | $90,963 |
| 2021 | 22 | 1,490 | 1,835 | $277,435 | $103,339 |
| 2020 | 23 | 1,677 | 2,018 | $255,748 | $100,305 |
Total Patients
6,989
Total Services
8,237
Medicare Billing
$373,347
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 141 | 179 | $44,992 | $12,822 | 28.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 229 | 231 | $31,878 | $11,622 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 172 | $24,156 | $10,322 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 72 | $18,000 | $5,866 | 32.6% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 70 | 70 | $17,524 | $5,672 | 32.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 35 | $17,394 | $5,485 | 31.5% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 42 | 42 | $13,608 | $3,985 | 29.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 443 | 556 | $10,008 | $3,401 | 34.0% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 19 | 19 | $7,639 | $3,236 | 42.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 46 | 46 | $7,884 | $2,488 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $8,640 | $2,146 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 31 | $5,580 | $1,675 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 34 | 34 | $6,120 | $1,506 | 24.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 23 | 23 | $4,968 | $1,472 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,360 | $1,387 | 41.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 312 | 312 | $9,048 | $1,368 | 15.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 53 | 53 | $2,332 | $816.50 | 35.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 16 | 16 | $2,048 | $792.60 | 38.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 69 | 70 | $2,170 | $721.87 | 33.3% |
| 0504T | Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | Facility | 2023 | 21 | 21 | $4,158 | $709.06 | 17.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 28 | 28 | $1,428 | $352.18 | 24.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 17 | 17 | $782.00 | $325.21 | 41.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 11 | 11 | $517.00 | $211.97 | 41.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 26 | 26 | $572.00 | $125.35 | 21.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 55 | 55 | $1,155 | $122.40 | 10.6% |
About Dr. Atul Chugh, M.D
Dr. Atul Chugh, M.D is a Cardiovascular Disease healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447463864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atul Chugh, M.D has received a total of $213,637 in payments from pharmaceutical and medical device companies, with $34,410 received in 2024. These payments were reported across 395 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,812).
As a Medicare-enrolled provider, Chugh has provided services to 6,989 Medicare beneficiaries, totaling 8,237 services with total Medicare billing of $373,347. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Indianapolis, IN
- Active Since 05/08/2007
- Last Updated 07/30/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447463864
Products in Payments
- Vascepa (Drug) $81,538
- WATCHMAN (Device) $22,989
- SAMSCA (Drug) $16,186
- WATCHMAN Access System (Device) $13,047
- ANGIOVAC (Device) $11,773
- SYMPLICITY G3 (Device) $8,386
- AngioVac (Device) $7,838
- Tryvio (Drug) $5,097
- ENTRESTO (Drug) $2,462
- RESOLUTE ONYX (Device) $2,322
- MK-1242 (Drug) $643.99
- Barostim Neo System (Device) $302.01
- BRILINTA (Drug) $245.35
- FFRct (Device) $177.93
- XARELTO (Drug) $174.23
- ELIQUIS (Drug) $163.90
- Impella (Device) $151.50
- CAMZYOS (Drug) $140.60
- LifeVest (Device) $138.51
- LEQVIO (Drug) $136.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Indianapolis
Eric Prystowsky, Md, MD
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Dr. Vijay Rao, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $431,147
Cardiovascular Disease $431,147
James Hermiller, Md, MD
Cardiovascular Disease — Payments: $380,511
Cardiovascular Disease $380,511
Noel Dasgupta, Md, MD
Cardiovascular Disease — Payments: $164,975
Cardiovascular Disease $164,975
Michael Ball, Md, MD
Cardiovascular Disease — Payments: $131,315
Cardiovascular Disease $131,315
Jeffrey Breall, M.d, M.D
Cardiovascular Disease — Payments: $120,157
Cardiovascular Disease $120,157